Scotia Capital Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Scotia Capital Inc.

$17 Billion
Q2 2024

A detailed history of Scotia Capital Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Scotia Capital Inc. holds 447 shares of REGN stock, worth $469,904. This represents 0.0% of its overall portfolio holdings.

Number of Shares

447

Previous 433 3.23%

Holding current value

$469,904

Previous $416,000 12.74%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $12,364 - $14,996	14 Added 3.23%	447 $469,000
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $19,859 - $21,853	22 Added 5.35%	433 $416,000
Q4 2023 Feb 12, 2024	BUY	$775.18 - $881.7 $90,696 - $103,158	117 Added 39.8%	411 $360,000
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $203,580 - $248,244	294 New	294 $241,000
Q4 2022 Feb 09, 2023	SELL	$705.89 - $766.39 $1,411 - $1,532	-2 Reduced 0.52%	383 $276,000
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $21,810 - $27,524	-38 Reduced 8.98%	385 $265,000
Q2 2022 Aug 05, 2022	BUY	$548.35 - $738.84 $46,061 - $62,062	84 Added 24.78%	423 $250,000
Q1 2022 May 09, 2022	SELL	$595.12 - $698.43 $2.38 Million - $2.79 Million	-3,997 Reduced 92.18%	339 $237,000
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $42,391 - $52,335	78 Added 1.83%	4,336 $2.74 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $1.82 Million - $2.16 Million	-3,175 Reduced 42.71%	4,258 $2.58 Million
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $1.21 Million - $1.43 Million	-2,563 Reduced 25.64%	7,433 $4.15 Million
Q1 2021 May 06, 2021	BUY	$446.73 - $548.2 $18,762 - $23,024	42 Added 0.42%	9,996 $4.73 Million
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $561,524 - $713,768	1,174 Added 13.37%	9,954 $4.81 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $503,349 - $608,186	924 Added 11.76%	8,780 $4.92 Million
Q2 2020 Aug 11, 2020	BUY	$493.32 - $643.92 $700,021 - $913,722	1,419 Added 22.04%	7,856 $4.9 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $1.98 Million - $2.91 Million	5,879 Added 1053.58%	6,437 $3.14 Million
Q4 2019 Feb 13, 2020	BUY	$274.13 - $376.51 $152,964 - $210,092	558 New	558 $210,000
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $262,795 - $305,972	-961 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $118,342 - $163,853	-395 Reduced 29.13%	961 $301,000
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $201,667 - $238,246	542 Added 66.58%	1,356 $557,000
Q4 2018 Feb 11, 2019	BUY	$335.82 - $403.04 $19,141 - $22,973	57 Added 7.53%	814 $304,000
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $5,618 - $6,536	-16 Reduced 2.07%	757 $306,000
Q2 2018 Aug 13, 2018	BUY	$284.6 - $344.99 $2,276 - $2,759	8 Added 1.05%	773 $262,000
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $241,602 - $301,241	765 New	765 $263,000

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account

Scotia Capital Inc. Regeneron Pharmaceuticals, Inc. Transaction History